Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

Henry Krum, Thomas Bigger, Rochelle L. Goldsmith, Milton Packer

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Objectives. This study was conducted to determine the effect of long-term digoxin therapy on autonomic function in patients with mild to moderate chronic heart failure. Background. Chronic heart failure is characterized by increased sympathetic activity and decreased parasympathetic activity. Intravenous digitalis has been found to reduce sympathetic activity immediately in these patients, but whether short-term neurohormonal effects are sustained during long-term oral therapy has not been assessed. Methods. We determined sympathetic activity in 26 patients with heart failure by measuring plasma norepinephrine levels and parasympathetic activity from variables of heart period variability derived from 24-h ambulatory electrocardiographic Holter recordings obtained before and after 4 to 8 weeks of digoxin therapy. Results. After digoxin therapy, plasma norepinephrine decreased significantly from a mean ± SEM of 552 ± 80 to 390 ± 37 ng/ml. In addition, the RR interval increaed significantly from 719 ± 19 to 771 ± 20 ms. High frequency power increased from 84 ± 24 to 212 ± 72ms2, and the root mean square of successive differences in RR interval increased from 203 ± 1.8 to 27.0 ± 3.4 ms, indicating a substantial increase in parasympathetic activity. Low frequency power, an index of baroreflex activity, was also significantly increased (239 ± 80 to 482 ± 144 ms2) by digoxin therapy. Conclusions. These results indicate 1) that long-term therapy with digoxin acts to ameliorate the autonomic dysfunction of patients with heart failure, and 2) that the short-term neurohormonal effects of digoxin are sustained during prolonged treatment with the drug.

Original languageEnglish (US)
Pages (from-to)289-294
Number of pages6
JournalJournal of the American College of Cardiology
Volume25
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Digoxin
Heart Failure
Therapeutics
Norepinephrine
Digitalis
Baroreflex
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Nursing(all)

Cite this

Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. / Krum, Henry; Bigger, Thomas; Goldsmith, Rochelle L.; Packer, Milton.

In: Journal of the American College of Cardiology, Vol. 25, No. 2, 1995, p. 289-294.

Research output: Contribution to journalArticle

Krum, Henry ; Bigger, Thomas ; Goldsmith, Rochelle L. ; Packer, Milton. / Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. In: Journal of the American College of Cardiology. 1995 ; Vol. 25, No. 2. pp. 289-294.
@article{1a76a3b5e29f45ef97e494fca7902d1c,
title = "Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure",
abstract = "Objectives. This study was conducted to determine the effect of long-term digoxin therapy on autonomic function in patients with mild to moderate chronic heart failure. Background. Chronic heart failure is characterized by increased sympathetic activity and decreased parasympathetic activity. Intravenous digitalis has been found to reduce sympathetic activity immediately in these patients, but whether short-term neurohormonal effects are sustained during long-term oral therapy has not been assessed. Methods. We determined sympathetic activity in 26 patients with heart failure by measuring plasma norepinephrine levels and parasympathetic activity from variables of heart period variability derived from 24-h ambulatory electrocardiographic Holter recordings obtained before and after 4 to 8 weeks of digoxin therapy. Results. After digoxin therapy, plasma norepinephrine decreased significantly from a mean ± SEM of 552 ± 80 to 390 ± 37 ng/ml. In addition, the RR interval increaed significantly from 719 ± 19 to 771 ± 20 ms. High frequency power increased from 84 ± 24 to 212 ± 72ms2, and the root mean square of successive differences in RR interval increased from 203 ± 1.8 to 27.0 ± 3.4 ms, indicating a substantial increase in parasympathetic activity. Low frequency power, an index of baroreflex activity, was also significantly increased (239 ± 80 to 482 ± 144 ms2) by digoxin therapy. Conclusions. These results indicate 1) that long-term therapy with digoxin acts to ameliorate the autonomic dysfunction of patients with heart failure, and 2) that the short-term neurohormonal effects of digoxin are sustained during prolonged treatment with the drug.",
author = "Henry Krum and Thomas Bigger and Goldsmith, {Rochelle L.} and Milton Packer",
year = "1995",
doi = "10.1016/0735-1097(94)00417-O",
language = "English (US)",
volume = "25",
pages = "289--294",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure

AU - Krum, Henry

AU - Bigger, Thomas

AU - Goldsmith, Rochelle L.

AU - Packer, Milton

PY - 1995

Y1 - 1995

N2 - Objectives. This study was conducted to determine the effect of long-term digoxin therapy on autonomic function in patients with mild to moderate chronic heart failure. Background. Chronic heart failure is characterized by increased sympathetic activity and decreased parasympathetic activity. Intravenous digitalis has been found to reduce sympathetic activity immediately in these patients, but whether short-term neurohormonal effects are sustained during long-term oral therapy has not been assessed. Methods. We determined sympathetic activity in 26 patients with heart failure by measuring plasma norepinephrine levels and parasympathetic activity from variables of heart period variability derived from 24-h ambulatory electrocardiographic Holter recordings obtained before and after 4 to 8 weeks of digoxin therapy. Results. After digoxin therapy, plasma norepinephrine decreased significantly from a mean ± SEM of 552 ± 80 to 390 ± 37 ng/ml. In addition, the RR interval increaed significantly from 719 ± 19 to 771 ± 20 ms. High frequency power increased from 84 ± 24 to 212 ± 72ms2, and the root mean square of successive differences in RR interval increased from 203 ± 1.8 to 27.0 ± 3.4 ms, indicating a substantial increase in parasympathetic activity. Low frequency power, an index of baroreflex activity, was also significantly increased (239 ± 80 to 482 ± 144 ms2) by digoxin therapy. Conclusions. These results indicate 1) that long-term therapy with digoxin acts to ameliorate the autonomic dysfunction of patients with heart failure, and 2) that the short-term neurohormonal effects of digoxin are sustained during prolonged treatment with the drug.

AB - Objectives. This study was conducted to determine the effect of long-term digoxin therapy on autonomic function in patients with mild to moderate chronic heart failure. Background. Chronic heart failure is characterized by increased sympathetic activity and decreased parasympathetic activity. Intravenous digitalis has been found to reduce sympathetic activity immediately in these patients, but whether short-term neurohormonal effects are sustained during long-term oral therapy has not been assessed. Methods. We determined sympathetic activity in 26 patients with heart failure by measuring plasma norepinephrine levels and parasympathetic activity from variables of heart period variability derived from 24-h ambulatory electrocardiographic Holter recordings obtained before and after 4 to 8 weeks of digoxin therapy. Results. After digoxin therapy, plasma norepinephrine decreased significantly from a mean ± SEM of 552 ± 80 to 390 ± 37 ng/ml. In addition, the RR interval increaed significantly from 719 ± 19 to 771 ± 20 ms. High frequency power increased from 84 ± 24 to 212 ± 72ms2, and the root mean square of successive differences in RR interval increased from 203 ± 1.8 to 27.0 ± 3.4 ms, indicating a substantial increase in parasympathetic activity. Low frequency power, an index of baroreflex activity, was also significantly increased (239 ± 80 to 482 ± 144 ms2) by digoxin therapy. Conclusions. These results indicate 1) that long-term therapy with digoxin acts to ameliorate the autonomic dysfunction of patients with heart failure, and 2) that the short-term neurohormonal effects of digoxin are sustained during prolonged treatment with the drug.

UR - http://www.scopus.com/inward/record.url?scp=0028877686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028877686&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(94)00417-O

DO - 10.1016/0735-1097(94)00417-O

M3 - Article

C2 - 7829779

AN - SCOPUS:0028877686

VL - 25

SP - 289

EP - 294

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 2

ER -